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Voltage-gated Na+ channels (VGSCs) in mammals contain a pore-forming α subunit and
one or more β subunits. There are ﬁve mammalian β subunits in total: β1, β1B, β2, β3,
and β4, encoded by four genes: SCN1B–SCN4B. With the exception of the SCN1B splice
variant, β1B, the β subunits are type I topology transmembrane proteins. In contrast, β1B
lacks a transmembrane domain and is a secreted protein. A growing body of work shows
that VGSC β subunits are multifunctional. While they do not form the ion channel pore, β
subunits alter gating, voltage-dependence, and kinetics of VGSCα subunits and thus regu-
late cellular excitability in vivo. In addition to their roles in channel modulation, β subunits
are members of the immunoglobulin superfamily of cell adhesion molecules and regulate
cell adhesion and migration. β subunits are also substrates for sequential proteolytic cleav-
age by secretases. An example of the multifunctional nature of β subunits is β1, encoded
by SCN1B, that plays a critical role in neuronal migration and pathﬁnding during brain
development, and whose function is dependent on Na+ current and γ-secretase activity.
Functional deletion of SCN1B results in Dravet Syndrome, a severe and intractable pedi-
atric epileptic encephalopathy. β subunits are emerging as key players in a wide variety
of physiopathologies, including epilepsy, cardiac arrhythmia, multiple sclerosis, Hunting-
ton’s disease, neuropsychiatric disorders, neuropathic and inﬂammatory pain, and cancer.
β subunits mediate multiple signaling pathways on different timescales, regulating elec-
trical excitability, adhesion, migration, pathﬁnding, and transcription. Importantly, some
β subunit functions may operate independently of α subunits. Thus, β subunits perform
critical roles during development and disease. As such, they may prove useful in disease
diagnosis and therapy.
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INTRODUCTION
Mammalian voltage-gated Na+ channels (VGSCs) exist as macro-
molecular complexes in vivo, comprising, at minimum, one pore-
forming α subunit and one or more β subunits in a 1:1 stoichiom-
etry for α:β (Catterall, 1992). Traditionally, VGSC β subunits have
been termed “auxiliary.” However, increasing evidence suggests
that the β subunits are far from auxiliary, and, in fact, function
as critical signaling molecules in their own right, perhaps even
independently of α subunits. In this review, we will summarize
the latest developments describing the growing, diverse, multi-
functional roles of the β subunits, including their contribution to
human disease.
MOLECULAR DIVERSITY AND FUNCTIONAL ARCHITECTURE
The topology of the canonicalVGSC complex is shown in Figure 1.
To date, ﬁve β subunits have been identiﬁed in mammals: β1, its
alternative splice variant β1B (previously called β1A), β2, β3, and
β4 (Isom et al., 1992, 1995; Kazen-Gillespie et al., 2000; Morgan
et al., 2000; Qin et al., 2003; Yu et al., 2003). Each β subunit is
encoded by one of four genes, SCN1B–SCN4B.With the exception
of β1B, the β subunits share a similar type I membrane topology,
including an extracellular N-terminal region immunoglobulin
(Ig) loop, one transmembrane domain, and a small intracellu-
lar C-terminal domain (Figure 2). β2 and β4 are disulﬁde linked
to VGSC α subunits, whereas β1 and β3 associate non-covalently
(Isom et al., 1992, 1995; Morgan et al., 2000; Yu et al., 2003). The
residues(s) responsible for the covalent interaction between β2/β4
and α have not yet been identiﬁed. Mutation studies have revealed
that the A/A′ strand of the β1 Ig fold contains critical charged
residues that interact with, andmodulate the activity of, the α sub-
unit whereas the intracellular domain is not involved (Mccormick
et al., 1998). Less is known about the β subunit interaction sites
on α subunits; however, an epilepsy-causing mutation, D1866Y, in
the C-terminal cytoplasmic domain of Nav1.1 disrupts modula-
tion of Na+ current by β1 (Spampanato et al., 2004). β1B shares
the same N-terminal Ig domain as β1, but by virtue of retention of
intron 3, has a different C-terminal region that lacks a transmem-
brane domain but contains a stop codon and polyadenylation site
(Kazen-Gillespie et al., 2000; Qin et al., 2003). As a result, β1B is
unique among the β subunits in that it is a soluble protein (Patino
et al., 2011). For reasons that are not understood, the amino acid
sequence of the β1B C-terminal domain is species-speciﬁc (Patino
et al., 2011). Further species-speciﬁc alternative splicing events
have been discovered within SCN1B, including splice variants of
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FIGURE 1 |Topology of the voltage-gated Na+ channel α and β subunits.
VGSCs contain a pore-forming α subunit consisting of four homologous
domains of six transmembrane segments (1–6). Segment 4 contains the
voltage sensor (Catterall, 2000). VGSCs also contain one or more β subunits.
β1, β2, β3, and β4 contain an extracellular immunoglobulin (Ig) loop,
transmembrane domain, and an intracellular C-terminal domain (Isom et al.,
1994). β1B also contains an Ig loop, but has a different C-terminus lacking a
transmembrane domain, and is thus a soluble, secreted protein (Patino et al.,
2011). β1 contains a tyrosine phosphorylation site in its C-terminus (Malhotra
et al., 2004) ψ, glycosylation sites. β1 and β3 are non-covalently linked to α,
whereas β2 and β4 are covalently linked through disulﬁde bonds. Figure was
produced using Science Slides 2006 software.
the zebraﬁsh SCN1B ortholog scn1ba, scn1ba_tv1, and scn1ba_tv2
(Fein et al., 2007) with altered protein structure, and β1.2 in rat
with an altered 3′ untranslated region (Dib-Hajj and Waxman,
1995). The tissue-speciﬁc expression proﬁles of each of the β sub-
units are subtly different, but clearly overlapping (Table 1). As
with the α subunits, β subunits are highly expressed in excitable
cells, including central and peripheral neurons, skeletal and car-
diac muscle cells (Isom et al., 1992, 1995; Morgan et al., 2000; Yu
et al., 2003; Maier et al., 2004; Lopez-Santiago et al., 2006, 2011;
Brackenbury et al., 2010). Importantly, however, increasing evi-
dence points to the expression of β subunits in a broad range
of traditionally non-excitable cells, including stem cells, glia, vas-
cular endothelial cells, and carcinoma cells (O’Malley and Isom,
manuscript in preparation; Diss et al., 2008; Chioni et al., 2009;
Andrikopoulos et al., 2011).
REGULATION OF EXCITABILITY BY INTERACTION WITH α
SUBUNITS
Beginning with the initial report of β1 cloning in 1992 (Isom
et al., 1992), numerous studies have demonstrated that all ﬁve
β subunits alter gating and kinetics of α subunits expressed in
heterologous cells (Catterall, 2000; Kazen-Gillespie et al., 2000;
Qin et al., 2003; Yu et al., 2003). For example, in both Xenopus
oocytes and mammalian cell lines, β1 and β2 increase the peak
Na+ current carried by Nav1.2, accelerate inactivation, and shift
the voltage-dependence of activation and inactivation to more
negative potentials (Isomet al., 1992, 1994, 1995).However, incon-
sistencies between different reports documenting the magnitude
and types of current modulation suggest that the cell background,
including expression of endogenous β subunits and/or other inter-
acting proteins, is a critical factor to consider when interpreting
the data (Moran et al., 2000, 2003;Meadows and Isom, 2005). Fur-
thermore, some of the more obvious effects of β1 and β2 on Na+
current gating and kinetics in heterologous cells, especially Xeno-
pus oocytes, do not appear to be reﬂected in vivo. In fact, results
from null mouse models suggest that the effects of β1 and β2 on
Na+ currents in vivo are subtle and cell type-speciﬁc (Chen et al.,
2002, 2004; Aman et al., 2009; Patino et al., 2009; Brackenbury
et al., 2010).
Voltage-gated Na+ channel β subunits have major effects on
cellular excitability in vivo, suggesting that their subtle effects on
Na+ currents are functionally signiﬁcant. For example, in Scn1b
null mice, the fastest components of the compound action poten-
tial are slowed in the optic nerve (Chen et al., 2004). The heart
rate is also slowed and action potentials in ventricular myocytes
are slower to repolarize resulting in QT prolongation (Lopez-
Santiago et al., 2007). Scn1b null mice are ataxic and, display
frequent spontaneous bilateral myoclonic seizures from postna-
tal day (P)8–10 (Chen et al., 2004). Action potentials in Scn1b
null CA3 neurons ﬁre with a signiﬁcantly higher peak voltage
and signiﬁcantly greater amplitude compared with wildtype neu-
rons (Patino et al., 2009). In addition, the action potential ﬁring
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FIGURE 2 | Functional architecture of β1/β1B. β1 contains residues
responsible for interaction with α subunit in its intracellular and
extracellular domains (Mccormick et al., 1998; Spampanato et al., 2004).
Mutation sites responsible for causing genetic epilepsy with febrile
seizures plus (GEFS+1), temporal lobe epilepsy (TLE), and Dravet
syndrome are located in the extracellular immunoglobulin loop (Meadows
et al., 2002;Wallace et al., 2002; Audenaert et al., 2003; Scheffer et al.,
2007; Patino et al., 2009). Alternative splicing site for β1B (Kazen-Gillespie
et al., 2000; Qin et al., 2003; Patino et al., 2011), putative palmitoylation
site (Mcewen et al., 2004), ankyrin interaction site (Malhotra et al., 2002),
tyrosine phosphorylation site (Malhotra et al., 2004), N -glycosylation sites
(ψ; Mccormick et al., 1998), α/β/γ-secretase cleavage sites (Wong et al.,
2005), receptor protein tyrosine phosphatase β (RPTPβ) interaction
(Ratcliffe et al., 2000), and putative fyn kinase interaction (Malhotra et al.,
2002, 2004; Brackenbury et al., 2008) are also marked. Figure was
produced using Science Slides 2006 software.
rate is reduced in Scn1b null cerebellar granule neurons (Brack-
enbury et al., 2010). Reduced action potential ﬁring in inhibitory
interneurons (e.g., GABAergic granule neurons) may lead to over-
all hyperexcitability within the neuronal network, and result in
hyperexcitability-related disorders, e.g., seizures (Oakley et al.,
2011). In contrast, Scn1b null nociceptive dorsal root ganglion
neurons are hyperexcitable (Lopez-Santiago et al., 2011). In the
latter example, the hyperexcitability is proposed to be due tomod-
ulationof bothNa+ andK+ currents byβ1orβ1B (Lopez-Santiago
et al., 2011). In support of this notion, β1 interacts with, andmod-
ulates, the gating of the inward rectiﬁer Kv4.3 in heterologous cells
(Deschenes et al., 2002, 2008).
β2 also regulatesVGSC α subunits in neurons, and thereby elec-
trical excitability. However, its role is proposed to be somewhat
different to β1, and its effects on channel kinetics and voltage-
dependence appear even subtler in vivo. Unlike Scn1b null mice,
Scn2b null mice appear normal in neurological tests, although
they display increased seizure susceptibility, and an elevated action
potential threshold in the optic nerve (Chen et al., 2002, 2004).
β2 associates with α subunits as the ﬁnal step in neuronal VGSC
biosynthesis, thereby permitting insertion of the complex into
the plasma membrane, and increasing Na+ current (Schmidt
and Catterall, 1986; Isom et al., 1995). Thus, β2 plays an impor-
tant role in stabilizing channel expression at the cell surface, and
thereby maintaining normal action potential threshold. In agree-
ment with this, there is∼50% decreased expression of α subunits
and Na+ currents at the plasma membrane of Scn2b null hip-
pocampal neurons (Chen et al., 2002). However, Scn2b deletion
has no effect on Na+ currents recorded from neurons isolated
from the dentate gyrus, suggesting that, similar to β1, its effects are
cell type-speciﬁc (Uebachs et al., 2010). In Scn2b null small-fast
dorsal root ganglion neurons, tetrodotoxin-sensitive Na+ current
is reduced by ∼50% and kinetics of activation and inactivation
are slowed. Consistent with this, the protein level of Nav1.7 is
reduced,whereas tetrodotoxin-resistantNa+ current is unchanged
(Lopez-Santiago et al., 2006). β2may therefore speciﬁcally regulate
tetrodotoxin-sensitive channels in vivo.
Similar to Scn2b null mice, Scn3b null mice behave normally
and have full lifespans (Chen et al., 2002; Hakim et al., 2008).
Scn1b may compensate for Scn3b deletion in brain, providing
for an apparently normal neurological phenotype (Hakim et al.,
2008, 2010a). Scn3b null hearts display ventricular arrhythmo-
genic properties, including shorter effective refractory periods,
induced tachycardia, and shorter action potential durations, corre-
sponding to reducedNa+ current and hyperpolarized inactivation
(Hakim et al., 2008). Atrial conduction abnormalities have also
been reported in Scn3b null mice (Hakim et al., 2010a). These
defects can be, in part, mitigated with the Class I antiarrhythmic
agents ﬂecainide and quinidine (Hakim et al., 2010b), supporting
the conclusion that β3 modulates α subunit function in the heart.
The β4 intracellular domain may regulate α subunits in cere-
bellar Purkinje neurons by acting as an open-channel blocker of
VGSCs that carry resurgent Na+ current (Grieco et al., 2005).
Silencing Scn4b in cerebellar granule neurons reduces resurgent
and persistent Na+ currents, hyperpolarizes voltage-dependence
of inactivation of transient current, and reduces repetitive action
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Table 1 |The β subunit family: tissue locations, interacting proteins, and disease association.
β subunit Gene Tissue locations Interacting proteins Disease Reference
β1 SCN1B CNS, heart, PNS, skeletal
muscle
AnkyrinB, ankyrinG, β1,
β2, contactin, Kv4.3,
NF155, NF186,
N -cadherin, NrCAM,
tenascin-R, RPTPβ
Epilepsy, cardiac
arrhythmia, cancer
Isom et al. (1992), Wallace et al. (1998), Xiao et al.
(1999),Malhotra et al. (2000), Ratcliffe et al. (2000),
Kaplan et al. (2001), Deschenes and Tomaselli
(2002), Malhotra et al. (2002), Meadows et al.
(2002), Wallace et al. (2002), Aronica et al. (2003),
Audenaert et al. (2003), Chen et al. (2004), Davis
et al. (2004), Malhotra et al. (2004), Mcewen and
Isom (2004), Fein et al. (2007), Lopez-Santiago
et al. (2007), Scheffer et al. (2007), Diss et al.
(2008), Fein et al. (2008), Chioni et al. (2009),
Watanabe et al. (2009), Brackenbury et al. (2010)
β1B SCN1B Adrenal gland, CNS, heart,
PNS, skeletal muscle
β1 Epilepsy Kazen-Gillespie et al. (2000), Qin et al. (2003),
Patino et al. (2011)
β2 SCN2B CNS, heart, PNS AnkyrinG β1, β2,
tenascin-C, tenascin-R
Altered pain
response, cardiac
arrhythmia, MS,
seizure susceptibility
Isomet al. (1995), Srinivasan et al. (1998), Xiao et al.
(1999), Malhotra et al. (2000), Chen et al. (2002),
Yu et al. (2003), Mcewen et al. (2004), Pertin et al.
(2005), Lopez-Santiago et al. (2006), O’Malley et al.
(2009), Watanabe et al. (2009)
β3 SCN3B Adrenal gland, CNS, heart,
kidney, PNS
NF186 Epilepsy, cardiac
arrhythmia,
traumatic nerve
injury
Morgan et al. (2000), Ratcliffe et al. (2001), Shah
et al. (2001), Adachi et al. (2004), Casula et al.
(2004), Chioni et al. (2009), Hu et al. (2009), Van
Gassen et al. (2009), Valdivia et al. (2010), Wang
et al. (2010), Olesen et al. (2011)
β4 SCN4B CNS, heart, PNS, skeletal
muscle
β1 Huntington’s
disease, long-QT
syndrome
Yu et al. (2003), Davis et al. (2004), Oyama et al.
(2006), Medeiros-Domingo et al. (2007), Aman
et al. (2009)
CNS, central nervous system; MS, multiple sclerosis; NF155, neurofascin-155; NF186, neurofascin-186; PNS, peripheral nervous system; RPTPβ, receptor protein
tyrosine phosphatase β.
potential ﬁring (Bant and Raman, 2010). Resurgent Na+current is
proposed to facilitate repetitive ﬁring in cerebellar neurons (Khaliq
et al., 2003; Bant and Raman, 2010). β4 thus appears to play a
key role in regulating excitability. Finally, β4 plays an antagonis-
tic role with β1 in regulating hippocampal neuron excitability: β4
slows inactivation and is proposed to promote excitability,whereas
β1 promotes inactivation and is proposed to act as a brake on
excitability (Aman et al., 2009). In summary, each of the β subunits
regulates excitability through interaction with, and modulation
of, α subunits in a cell type-speciﬁc and channel subtype-speciﬁc
manner.
NON-CONDUCTING FUNCTIONS
β subunits are multifunctional (Figure 2). In addition to their
“conducting”role inmodulatingNa+ current kinetics and voltage-
dependence, they are members of the Ig superfamily of cell
adhesionmolecules (CAMs) and participate in a number of “non-
conducting” cell adhesion related activities (Isom et al., 1995; Yu
et al., 2003). β1 and β2 both participate in trans-homophilic adhe-
sion resulting in cellular aggregation and recruitment of ankyrin
to points of cell–cell contact in Drosophila S2 cells (Malhotra
et al., 2000). By contrast, β3, in spite of its high homology to β1,
does not mediate homophilic adhesion (Mcewen et al., 2009) but
participates in heterophilic adhesion (see below). Phosphorylation
of tyrosine residue (Y)181 in the intracellular domain of β1 abro-
gates the recruitment of ankyrinB and ankyrinG in transfectedChi-
nese hamster lung cells (Malhotra et al., 2002). In cardiacmyocytes,
phosphorylation of Y181 determines localization of β1 to inter-
calated disks with connexin-43, N -cadherin, and Nav1.5, while
non-phosphorylated β1 localizes in the t-tubules with ankyrinB
(Malhotra et al., 2004). Thus, the phosphorylation state of Y181
may be important for regulating the subcellular distribution of β1.
Interestingly, the intracellular domain of β1 interacts with recep-
tor protein tyrosine phosphatase-β in rat brain neurons (Ratcliffe
et al., 2000), potentially providing a mechanism for regulating
Y181 phosphorylation. In addition, indirect evidence suggests that
β1-mediated trans-homophilic adhesion results in fyn kinase acti-
vation in mouse cerebellar granule neurons (Brackenbury et al.,
2008), which in turn could further ﬁne tune phosphorylation of
Y181.
The β subunits interact heterophilically with several other
CAMs and extracellular matrix proteins. β1 interacts with VGSC
β2, contactin, neurofascin-155, neurofascin-186, NrCAM, N -
cadherin (Kazarinova-Noyes et al., 2001; Ratcliffe et al., 2001;Mal-
hotra et al., 2004; Mcewen and Isom, 2004). Interaction between
β1 and contactin, neurofascin-186, or VGSC β2 increases Na+
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current in heterologous systems (Kazarinova-Noyes et al., 2001;
Mcewen et al., 2004), suggesting that β subunit-dependent adhe-
sionmay regulate α subunit function and excitability. Both β1 and
β2 interact with the extracellular matrix protein tenascin-R (Xiao
et al., 1999). β2 also interacts with tenascin-C (Srinivasan et al.,
1998), but does not interact with contactin (Mcewen et al., 2004).
Less is known about the heterophilic interactions of the other β
subunits. β3, which does not interact with either β1 or contactin,
does interact with neurofascin-186 (Ratcliffe et al., 2001; Mcewen
et al., 2009). Although similar studies have not been performed for
β1B, it has been proposed that its heterophilic binding partners are
likely similar to those of β1, given that both molecules share an
identical Ig domain (Patino and Isom, 2010).
β1, β2, β3, and β4 subunits are substrates for sequential pro-
teolytic cleavage by enzymes from the secretase family. These β
subunits contain cleavage sites for the β-site amyloid precursor
protein-cleaving enzyme 1 (BACE1) on the extracellular domain,
adjacent to the transmembrane region (Wong et al., 2005; Gers-
bacher et al., 2010). β2 also contains a cleavage site for the α-
secretase enzyme ADAM10 in the extracellular juxtamembrane
region (Kim et al., 2005). Cleavage by BACE1 or α-secretase results
in shedding of the extracellular Ig domain, leaving transmembrane
C-terminal fragments (Kim et al., 2005; Wong et al., 2005). The
C-terminal fragments are subsequently processed by γ-secretase
at a site in the intracellular juxtamembrane region, thus releasing
soluble intracellular domains into the cytoplasm (Kim et al., 2005;
Wong et al., 2005). Although these four β subunits are cleaved by
BACE1 in vitro, processing in vivo has so far been demonstrated
only for β2 and β4 (Wong et al., 2005). Importantly, the signaling
events responsible for initiating β subunit processing by the secre-
tases, as well as potential developmental timing of these cleavage
events in vivo, have not been investigated.
The functional effects of processing these β subunits appear
critical to their in vivo function. For example, both the extracel-
lular domain of β1, and its soluble splice variant, β1B, promote
neurite outgrowth (Davis et al., 2004; Patino et al., 2011). Sim-
ilarly, cleavage of the extracellular domain of β4 by BACE1 also
increases neurite outgrowth (Miyazaki et al., 2007). Inhibition
of γ-secretase activity reduces β2-dependent cell adhesion and
migration, suggesting that the intracellular domain is important
for promoting these functions (Kim et al., 2005). The β2 intracel-
lular domain translocates to the nucleus of transfected SH-SY5Y
cells and increases expression of SCN1A, suggesting that it may
function, directly or indirectly, as a transcriptional regulator of
VGSC α subunit expression (Kim et al., 2007). Further, the mRNA
and protein levels of Scn1a/Nav1.1 are reduced in the brains of
Bace1 null mice (Kim et al., 2011). Altered expression of α subunit
mRNA and protein in the peripheral and central nervous systems
of Scn1b and Scn2b null mice, as well as the hearts of Scn1b and
Scn3b null mice (Chen et al., 2004; Lopez-Santiago et al., 2006,
2007, 2011; Hakim et al., 2008; Brackenbury et al., 2010), sug-
gests that regulation of α subunit expression by β subunits may be
widespread. Finally, cleavage of β4 by BACE1 in cerebellar Purk-
inje cells slows the decay of resurgentNa+ current, thus promoting
actionpotential ﬁring (Huth et al., 2011), suggesting that secretase-
mediated β subunit processing may modulate α subunit activity
and thus neuronal excitability. However, another study from the
same group indicated that BACE1 modulates α subunit gating in
transfected human embryonic kidney cells and murine neurob-
lastoma cells, independent of its proteolytic effect on β2 and β4
(Huth et al., 2009). Thus the effects of BACE1 on α and β subunit
function appear complex. Further work is required to understand
the regulatory events involved in this putative signaling cascade
and to establish whether BACE1 does indeed directly interact with
α subunits in addition to β subunits.
ROLE OF β SUBUNITS IN DEVELOPMENT
β1 promotes neurite outgrowth in cerebellar granule neurons
through trans-homophilic cell–cell adhesion (Davis et al., 2004).
This mechanism operates through lipid rafts and requires fyn
kinase, contactin, and Na+ current (Brackenbury et al., 2008,
2010). β1-mediated neurite outgrowth also requires γ-secretase
activity, suggesting that proteolytic processing of the intracellular
domain may be important (Figures 3A,B). In contrast, neither
β2 nor β4 promote neurite outgrowth in cerebellar granule neu-
rons (Davis et al., 2004). However, β4 enhances neurite extension
in neuroblastoma cells, and increases dendritic spine density in
hippocampal neurons (Oyama et al., 2006; Miyazaki et al., 2007).
In addition, β1 and β2 regulate the migration of ﬁbroblasts away
from the extracellularmatrix protein tenascin-R (Xiao et al., 1999).
FIGURE 3 | β1-mediated neurite outgrowth requires γ-secretase
activity. (A) Location of γ-secretase cleavage site on the intracellular
domain of β1 (Wong et al., 2005). (B) Cerebellar granule neurons from
postnatal day (P)14 wildtype mice were plated on top of monolayers of
control or β1-expressing Chinese hamster lung cells, as described
previously (Davis et al., 2004). Cultures were incubated with the either one
of the γ-secretase inhibitors, L685458, or DAPT (both 1μM); or control
(DMSO) for 48 h (Kim et al., 2005). Cells were then ﬁxed, processed for
GAP43 immunocytochemistry, and neurite lengths measured, as described
(Davis et al., 2004). Both L685458 and DAPT inhibited the increase in
neurite length caused by β1 expressed in the monolayer. Data are
mean+SEM (n =300). Signiﬁcance: ***P <0.001, ANOVA with Tukey’s
post hoc test.
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Finally, β1 inhibits the migration of metastatic breast cancer cells
(Chioni et al., 2009). Thus, β subunit-mediated neurite outgrowth
and migration may be subtype and/or cell-speciﬁc.
The regulation of neurite outgrowth and migration by β sub-
units has consequences for development and organogenesis. In
particular, β1 plays a critical role in neuronal pathﬁnding in
postnatal-developing ﬁber tracts, coinciding with the onset of its
expression from birth (Sutkowski and Catterall, 1990; Sashihara
et al., 1995; Brackenbury et al., 2008). Scn1b null mice display a
severe phenotype that includes growth retardation, ataxia, spon-
taneous seizures from P8–10, and death by P21 (Chen et al.,
2004). In P14–16 Scn1b null mice, the pathﬁnding and migration
of corticospinal axons is disrupted, leading to signiﬁcant defas-
ciculation of ﬁbers at the pyramidal decussation (Brackenbury
et al., 2008). The cerebellar parallel ﬁbers are also defascicu-
lated in P14 Scn1b null mice. The migration of granule neurons
through the cerebellar molecular layer is disrupted, resulting in
their accumulation in the external germinal layer, which is conse-
quently thicker in Scn1b null mice than in wildtype littermates
(Brackenbury et al., 2008). These cerebellar defects may con-
tribute to the ataxic phenotype (Chen et al., 2004). Consistent
with results in mice, abnormal pathﬁnding has also been reported
in the olfactory nerve of zebraﬁsh scn1bb morphants (Fein et al.,
2008).
An important next step will be to determine whether defects in
Scn1b-mediated cell–cell adhesion and migration in brain occur
prior to the onset of convulsive seizures (Chen et al., 2004). It
is possible that abnormal neuronal migration and pathﬁnding in
the absence of β1/β1B-mediated cell adhesive interactions may
lead to aberrant connections, resulting in neuronal hyperexcitabil-
ity and epileptogenesis. Further work is required to establish the
causational relationship between β1/β1B expression, cell adhe-
sion,migration, and seizures during postnatal development of the
nervous system.
ALTERATIONS IN VGSC PHARMACOLOGY BY β SUBUNITS
Studies have indicated that β subunits can alter the effect of phar-
macological compounds on Na+ currents carried by α subunits.
For example,usingheterologous systems,co-expressionof β1orβ3
with Nav1.3 in Xenopus oocytes attenuates the inhibitory effect of
the antiarrhythmic agent and local anesthetic lidocaine on current
amplitude and inactivation (Lenkowski et al., 2003). Further, the
β1 C121W epilepsy mutation reduces tonic and use-dependent
channel block in response to the antiepileptic drug phenytoin
(Lucas et al., 2005). This altered sensitivity to phenytoin is pro-
posed to be as a result of the altered gating caused by the mutation
(Meadows et al., 2002), rather than a direct effect on the drug
receptor. A recent in vivo study showed that the use-dependent
reduction of transient Na+ current caused by the anticonvulsant
drug carbamazepine in wildtype hippocampal neurons was not
observed in Scn1b or Scn2b null hippocampal neurons (Uebachs
et al., 2010).However, carbamazepine caused a small hyperpolariz-
ing shift in the voltage-dependence of activation of both transient
and persistent Na+ current. The hyperpolarizing shift in persis-
tent Na+ current was signiﬁcantly increased in Scn1b null neurons
at low carbamazepine concentrations, resulting in a complete loss
in efﬁcacy of the drug to reduce repetitive action potential ﬁring
(Uebachs et al., 2010). Thus, β1/β1B alters the pharmacological
response of persistent Na+ current to carbamazepine. Finally, in
Scn3b null hearts, the VGSC-blocking antiarrhythmic agents ﬂe-
cainide and quinidine both modify ventricular effective refractory
periods, resulting in anti-arrhythmogenic effects, in contrast to
their effects in wildtype or Scn5a mutant hearts (Hakim et al.,
2010b). Taken together, these ﬁndings have important clinical
implications, suggesting that function-altering mutations and/or
altered expression or localization of β subunits in patients may
affect their sensitivity to VGSC-targeting drugs and thus ther-
apeutic efﬁcacy. Further work is required to establish whether
or not β subunits alter pharmacological responses to additional
VGSC-targeting therapeutics.
FUNCTIONAL RECIPROCITY BETWEEN α AND β SUBUNITS
Extensive evidence indicates that β subunits modulate channel
gating of α subunits (see Regulation of Excitability by Interac-
tion with α Subunits). Similarly, β1-mediated neurite outgrowth
is inhibited by the VGSC-blocking toxin tetrodotoxin (Bracken-
bury et al., 2010). Thus, there is a potential for interplay between
β1-mediatedmodulation of Na+ current carried byα subunits and
β1-mediated cell–cell adhesion/migration. β1 is required for nor-
mal high-frequency action potential ﬁring in cerebellar granule
neurons (Figure 4A). β1-mediated neurite outgrowth is abro-
gated in Scn8a null cerebellar granule neurons, suggesting that the
mechanism requires Na+ current carried by Nav1.6 (Figure 4B).
Nav1.6 is vital for high-frequency repetitive ﬁring in cerebellar
neurons (Raman and Bean, 1997). Resurgent Na+ current, car-
ried by Nav1.6, and which facilitates repetitive action potential
ﬁring (Raman and Bean, 1997; Khaliq et al., 2003; Bant and
Raman, 2010), is reduced in Scn1b null cerebellar granule neurons
(Brackenbury et al., 2010). The Scn1b null mutation disrupts the
expression of Nav1.6 at the axon initial segment (AIS) of cerebellar
granule neurons (Figure 4C).
Taken together, these data suggest that there is a functional
reciprocity between β1 and Nav1.6 in cerebellar neurons, such
that, on the one hand, β1 is required for normal localization of
Nav1.6 at the AIS, thus permitting resurgent Na+ current, and
repetitive action potential ﬁring. On the other hand, Nav1.6 is
required for β1-mediated neurite outgrowth. Electrical activity
generated at the AIS is proposed to provide a depolarizing signal
to openNav1.6 channels at the growth cone, further promotingβ1-
mediatedneurite outgrowth (Figure 4D; Brackenbury et al., 2008).
This reciprocal relationship between β1 and Nav1.6 is critical for
postnatal cerebellar development (Chen et al., 2004;VanWart and
Matthews, 2006). Impaired localization of β1 at the AIS may thus
lead to altered excitability. In agreement with this, in knock-in
mice heterozygous for the β1C121W mutation, which disrupts
β1-dependent adhesion and alters channel gating, mutant β1 pro-
tein is excluded from the AIS of pyramidal neurons, potentially
contributing to febrile seizures (Meadows et al., 2002; Wimmer
et al., 2010).
Future work will no doubt establish whether or not further
complementary roles exist betweenVGSC α and β subunits, inter-
acting in a coordinated fashion to regulate processes including
excitability and neurite extension. It is already clear however, that
β subunits function inmacromolecular complexes with α subunits
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FIGURE 4 | Functional reciprocity between β1 and Nav1.6. (A) Electrical
excitability is impaired in Scn1b null cerebellar granule neurons. Action
potential ﬁring rate recorded from cerebellar granule neurons in brain
slices from 12-day-old mice plotted as a function of injected current,
normalized to action potential threshold for wildtype (ﬁlled circles) and
Scn1b null (open circles). Data are mean±SEM (n ≥15). Signiﬁcance:
*P <0.05; **P <0.01; ***P <0.001; t -test. (B) β1-mediated neurite
outgrowth is inhibited by the Scn8a null mutation. Neurite lengths of
wildtype and Scn8a null cerebellar granule neurons grown on control
Chinese hamster lung or β1-expressing monolayers (n =300). Data are
mean+SEM. Signiﬁcance: ***P <0.001, ANOVA with Tukey’s post hoc
test. (C) Nav1.6 expression is reduced at the axon initial segment of Scn1b
null cerebellar granule neurons.Wildtype and Scn1b null cerebellar granule
neurons cultured in vitro for 14 days labeled with anti-ankyrinG (red) and
Nav1.6 antibodies (green). Scale bar, 20μm. Arrows point to axon initial
segment expressing ankyrinG. (D) A model for Na+ current involvement in
β1-mediated neurite outgrowth. Complexes containing Nav1.6, β1, and
contactin are present throughout the neuronal membrane in the soma,
neurite and growth cone. Localized Na+ inﬂux is necessary for
β1-mediated neurite extension and migration. VGSC complexes along the
neurite participate in cell–cell adhesion and fasciculation. β1 is also
required for Nav1.6 expression at the axon initial segment, and subsequent
high-frequency action potential ﬁring through modulation of resurgent
Na+current. Electrical activity may further promote β1-mediated neurite
outgrowth at or near the growth cone. Thus, the developmental functions
of β1 and Nav1.6 are complementary, such that (1) Na+ inﬂux carried by
Nav1.6 is required for β1-mediated neurite outgrowth, and (2) β1 is required
for normal expression/activity of Nav1.6 at the axon initial segment. Fyn
kinase and ankyrinG are likely also present in all complexes, but are only
shown once in each panel for clarity. The FGF-mediated, β1-independent
neurite outgrowth pathway is also shown. Figure reproduced with
permission (Brackenbury et al., 2010).
to participate in signaling on multiple timescales to regulate
excitability, adhesion, neurite outgrowth, and migration. A crit-
ical focus of future work will be to determine whether β subunits
that are expressed independently of the ion-conducting pore also
play roles in excitability in vivo, perhaps through regulation of
axon guidance or fasciculation.
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DYSREGULATION IN DISEASE
Voltage-gated Na+ channel β subunits are implicated in a num-
ber of neurological diseases (Table 1) [reviewed extensively in
Patino and Isom (2010)]. Of particular note is the growing list
of mutations in SCN1B that are associated with genetic epilepsy
with febrile seizures plus (GEFS)+ 1 (OMIM 604233), a spec-
trum of disorders that includes mild to severe forms of epilepsy
(Wallace et al., 1998, 2002; Audenaert et al., 2003; Burgess, 2005;
Yamakawa, 2005; Scheffer et al., 2007; Patino et al., 2009, 2011). No
GEFS+ 1-causing mutations in the other β subunit genes have yet
been identiﬁed.However,Scn2b nullmice display increased seizure
susceptibility (Chen et al., 2002). In addition, SCN3B is reduced
in the hippocampus of patients with temporal lobe epilepsy, sug-
gesting that altered β3 expression may contribute to or result
from epilepsy (Van Gassen et al., 2009). The mutations in SCN1B
may bias neurons toward hyperexcitability and epileptogenesis by
one or both of two distinct mechanisms: (1) impaired regula-
tion of α subunit-dependent excitability (Meadows et al., 2002;
Chen et al., 2004; Spampanato et al., 2004; Patino et al., 2009;
Wimmer et al., 2010); and/or (2) impaired cell–cell adhesive inter-
actions (Meadows et al., 2002; Brackenbury et al., 2008; Fein et al.,
2008; Patino et al., 2011). There may also be a causal relationship
between VGSC α-β1 interactions, cell–cell adhesion, migration,
and epilepsy. Further work is required to establish whether or not
disrupted β1-dependent cell adhesion is indeed a prerequisite for
seizure activity.
Changes in β2 expression have been implicated in altered pain
sensation. Scn2b null mice are more sensitive to noxious thermal
stimuli than wildtype mice (Lopez-Santiago et al., 2006). In addi-
tion, the spared nerve injury model of neuropathic pain results
in increased β2 expression in rat sensory neurons, and mechan-
ical allodynia-like behavior (Pertin et al., 2005). This behavior is
absent in Scn2b null mice, suggesting that β2 expression may play
an important role in neuropathic pain sensation (Pertin et al.,
2005).
The β subunits play roles in neurodegenerative disease. The
Scn2b null mutation is neuroprotective in the experimental aller-
gic encephalomyelitismousemodel ofmultiple sclerosis (O’Malley
et al., 2009). In addition, levels of Scn4b are reduced in mouse
models of Huntington’s disease prior to onset of motor symp-
toms, and a similar reduction has also been reported in patients
(Oyama et al., 2006).
Indirect evidence suggests that β subunits may be involved in
neuropsychiatric disorders. For example, ankyrinG and Nav1.6,
which both interact with β subunits, are linked genetically to
bipolar disorder (Gargus, 2006; Wang et al., 2008). Migration
defects observed in the cerebellum of Scn1b null mice may result
in abnormal connections with the prefrontal cortex and poste-
rior parietal cortex, thus providing a possible mechanism for
β subunit involvement in mood disorders (Brackenbury et al.,
2008; Strick et al., 2009). Similarly, migration defects in other
brain areas in patients with SCN1B mutations may contribute
to mental disorders. Pathological cellular migration regulated by
β subunits extends beyond neurological diseases: β1 regulates cel-
lular adhesion and migration in metastatic breast cancer cell lines
(Chioni et al., 2009). β subunit transcripts are also expressed in
prostate cancer cells and lung cancer cells (Roger et al., 2007; Diss
et al., 2008), suggesting that their involvement in cancer may be
widespread.
Finally, mutations in β subunits are associated with cardiac
abnormalities (Wilde and Brugada, 2011). Mutations in SCN1B
have been reported in patients with idiopathic ventricular ﬁb-
rillation (Brugada syndrome; Watanabe et al., 2008; Hu et al.,
2009; Valdivia et al., 2010). Mutations in SCN1B, SCN2B, and
SCN3B are also associated with atrial ﬁbrillation (Watanabe et al.,
2009; Wang et al., 2010; Olesen et al., 2011). Mutations in SCN3B
and SCN4B are associated with sudden infant death syndrome
(Tan et al., 2010). These mutations are proposed to interfere with
the ability of β subunits to modulate Nav1.5 currents in vivo
(Watanabe et al., 2008, 2009; Hu et al., 2009; Tan et al., 2010).
A mutation in SCN4B results in long-QT syndrome (Medeiros-
Domingo et al., 2007). Expression of amutation linked to conduc-
tion disease and Brugada syndrome, Scn5a1798insD/+, in a mouse
strain (129P2) with markedly reduced Scn4b expression resulted
in more severe cardiac conduction slowing than a strain with
normal Scn4b levels (FVB/N), suggesting that Scn4b may be a
genetic modiﬁer of cardiac conduction (Remme et al., 2009). In
summary, abnormal expression and/or function of β subunits
appears to play an important role in a number of diseases, rang-
ing from nervous system disorders, to cardiac abnormalities, and
cancer.
CONCLUSION/OUTLOOK
Increasing new evidence supports the hypothesis that the VGSC
β subunits are multifunctional. In addition, a growing list of
mutations and in vivo studies indicate that the β subunits play
important roles in a number of diseases due to abnormal func-
tion in both excitable and non-excitable cells. There is no doubt
that the classical “conducting” role of β subunits as modula-
tors of Na+current is of paramount importance in regulating
ion ﬂux and excitability. However, there is a clear trend in
the literature toward an increasingly important role for “non-
conducting” functions, including cell adhesion, migration and
pathﬁnding, and putative transcriptional regulation. As a result,
the β subunits are integral components of VGSC macromol-
ecular protein complexes, which can direct multiple signaling
mechanisms on multiple timescales. Moreover, the cell adhesive,
“non-conducting” properties of β subunits observed in vitro sug-
gest that they may play critical functional roles independent of
α subunits in vivo. The challenge now will be to clearly delin-
eate the cell adhesive functions of β subunits from their roles
in channel modulation during development and in pathophys-
iology. Clearer understanding of the interaction between the
conducting and non-conducting functions of VGSC complexes
will hopefully enable the full realization of their therapeutic
potential.
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